Copeland Capital Discloses 1.26M Share Stake in Lemaitre Vascular

TL;DR

**Copeland Capital just revealed a big stake in Lemaitre Vascular, signaling institutional confidence.**

AI Summary

Copeland Capital Management, LLC, a Delaware-based investment firm, reported beneficial ownership of 1,259,961 shares of Lemaitre Vascular Inc. (LMAT) Common Stock as of December 31, 2023. This represents a significant stake, with the firm holding sole voting power over 892,607 shares and shared voting power over 94,937 shares. This matters to investors because it signals that a professional money manager sees value in LMAT, potentially indicating a vote of confidence in the company's future performance.

Why It Matters

This filing shows a major institutional investor, Copeland Capital Management, has a substantial position in Lemaitre Vascular, which can be seen as a positive signal for the stock's prospects.

Risk Assessment

Risk Level: low — This filing indicates an institutional investment, generally a positive sign, and does not present immediate risks.

Analyst Insight

A smart investor would view this institutional filing as a positive indicator and might consider further research into Lemaitre Vascular Inc.'s fundamentals and recent performance, as a significant stake by a professional money manager often suggests confidence in the company's value.

Key Numbers

• 1,259,961 — Aggregate Shares Beneficially Owned (Total shares of Lemaitre Vascular Inc. held by Copeland Capital Management, LLC as of December 31, 2023.)
• 892,607 — Sole Voting Power Shares (Number of shares over which Copeland Capital Management, LLC has exclusive voting control.)
• 94,937 — Shared Voting Power Shares (Number of shares over which Copeland Capital Management, LLC shares voting control.)
• December 31, 2023 — Date of Event (The specific date that triggered the requirement for this SC 13G filing.)

Key Players & Entities

• Copeland Capital Management, LLC (company) — the reporting person, an investment firm
• Lemaitre Vascular Inc. (company) — the subject company whose stock is being reported
• Delaware (company) — state of incorporation for Copeland Capital Management, LLC
• 1,259,961 (dollar_amount) — aggregate shares beneficially owned by Copeland Capital Management, LLC
• 892,607 (dollar_amount) — shares with sole voting power held by Copeland Capital Management, LLC
• 94,937 (dollar_amount) — shares with shared voting power held by Copeland Capital Management, LLC
• December 31, 2023 (date) — date of event requiring the filing

Forward-Looking Statements

• Other institutional investors may increase their positions in Lemaitre Vascular Inc. following Copeland Capital Management's disclosed stake. (Lemaitre Vascular Inc.) — medium confidence, target: Next 6-12 months

FAQ

Filing Documents

• lemaitre_sc13g.htm (SC 13G) — 68KB
• sc001_v1.jpg (GRAPHIC) — 4KB
• 0001580642-24-000331.txt ( ) — 75KB

From the Filing

SC 13G 1 lemaitre_sc13g.htm SC 13G UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ______)* LEMAITRE VASCULAR INC (Name of Issuer) Common Stock (Title of Class of Securities) 525558201 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: x Rule 13d-1(b) o Rule 13d-1(c) o Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ). SCHEDULE 13G CUSIP No. 525558201 1 Names of Reporting Persons Copeland Capital Management, LLC 2 Check the appropriate box if a member of a Group (see instructions) (a) o (b) o 3 Sec Use Only 4 Citizenship or Place of Organization Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 892,607 6 Shared Voting Power 94,937 7 Sole Dispositive Power 8 Shared Dispositive Power 1,259,961 9 Aggregate Amount Beneficially Owned by Each Reporting Person 1,259,961 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) o 11 Percent of class represented by amount in row (9) 5.7% 12 Type of Reporting Person (See Instructions) IA Page 2 of 5 Item 1. (a) Name of Issuer: LEMAITRE VASCULAR INC (b) Address of Issuers Principal Executive Offices: 63 Second Avenue Burlington, Massachusetts Item 2. (a) Name of Person Filing: Sofia A. Rosala (b) Address of Principal Business Office or, if None, Residence: 161 Washington St, Suite 1325, Conshohocken, PA 19428 (c) Citizenship: U.S.A (d) Title and Class of Securities: Common Stock (e) CUSIP No.: 525558201 Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) o Broker or dealer registered under Section 15 of the Act; (b) o Bank as defined in Section 3(a)(6) of the Act; (c) o Insurance company as defined in Section 3(a)(19) of the Act; (d) o Investment company registered under Section 8 of the Investment Company Act of 1940; (e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) o A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); (k) o Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Page 3 of 5 Item 4. (a) Amount Beneficially Owned: 1,259,961 (b) Percent of Class: 5.7% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 892,607 (ii) Shared power to vote or to direct the vote: 189,875 (iii) Sole power to dispose or to direct the disposition of: 1,259,961 (iv) Shared power to dispose or to direct the disposition of: Item 5. of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial Item 6. of more than Five Percent on Behalf of Another Person. Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. Item 8. Identification and classification of members of the group. Item 9. Notice of Dissolution of Group. Item 10. Certifications. Page 4 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 19, 2024 /s/ Signature Name/Title Sofia A. Rosala, General Counsel and CCO The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a pe

View Full Filing

View this SC 13G filing on SEC EDGAR